The ways and means that fine tune Sirt1 activity

Trends in Biochemical Sciences

Volumn 38, Issue 3, 2013, Pages 160-167

  Revollo, Javier R ^a   Li, Xiaoling ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Aging; Energy metabolism; Metabolic sensor; Nutrients; Sirt1

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HISTONE LYSINE METHYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; SIRTUIN 1; SIRTUIN 2; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1;

CATALYSIS; DEACETYLATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; HUMAN; HYDROLYSIS; INSULIN RELEASE; MASS SPECTROMETRY; MOLECULAR DYNAMICS; MOLECULAR EVOLUTION; NITROSYLATION; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METHYLATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SUMOYLATION; UBIQUITINATION;

ANIMALS; HUMANS; SIRTUIN 1;

MAMMALIA;

EID: 84874228973     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2012.12.004     Document Type: Review

References (83)

1. Tanner K.G., et al. Silent information regulator 2 family of NAD- dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:14178-14182.
2. Imai S., et al. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 2000, 403:795-800.
3. +: an old metabolite controlling new metabolic signaling pathways. Endocr. Rev. 2010, 31:194-223.
4. Rodgers J.T., et al. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005, 434:113-118.
5. Chen D., et al. Tissue-specific regulation of SIRT1 by calorie restriction. Genes Dev. 2008, 22:1753-1757.
6. +-dependent protein deacetylase, via activation of PPARalpha in mice. Mol. Cell. Biochem. 2010, 339:285-292.
7. Graham T.E., Saltin B. Estimation of the mitochondrial redox state in human skeletal muscle during exercise. J. Appl. Physiol. 1989, 66:561-566.
8. Chabi B., et al. Relationship between Sirt1 expression and mitochondrial proteins during conditions of chronic muscle use and disuse. J. Appl. Physiol. 2009, 107:1730-1735.
9. + metabolism and SIRT1 activity. Nature 2009, 458:1056-1060.
10. Canto C., et al. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab. 2010, 11:213-219.
11. + intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 2011, 14:528-536.
12. Kim H.J., et al. Metabolomic analysis of livers and serum from high-fat diet induced obese mice. J. Proteome Res. 2011, 10:722-731.
13. Kendrick A.A., et al. Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation. Biochem. J. 2011, 433:505-514.
14. Tao R., et al. Hepatic FoxOs regulate lipid metabolism via modulation of expression of the nicotinamide phosphoribosyltransferase gene. J. Biol. Chem. 2011, 286:14681-14690.
15. + metabolism in health and disease. Trends Biochem. Sci. 2007, 32:12-19.
16. Imai S. A possibility of nutriceuticals as an anti-aging intervention: activation of sirtuins by promoting mammalian NAD biosynthesis. Pharmacol. Res. 2010, 62:42-47.
17. Gibson B.A., Kraus W.L. New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs. Nat. Rev. Mol. Cell Biol. 2012, 13:411-424.
18. Virag L. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies. Curr. Vasc. Pharmacol. 2005, 3:209-214.
19. Bai P., et al. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab. 2011, 13:461-468.
20. Chini E.N. CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions. Curr. Pharm. Design 2009, 15:57-63.
21. Sasaki T., et al. Phosphorylation regulates SIRT1 function. PLoS ONE 2008, 3:e4020.
22. Nasrin N., et al. JNK1 phosphorylates SIRT1 and promotes its enzymatic activity. PLoS ONE 2009, 4:e8414.
23. Vinciguerra M., et al. mIGF-1/JNK1/SirT1 signaling confers protection against oxidative stress in the heart. Aging Cell 2012, 11:139-149.
24. Guo X., et al. DYRK1A and DYRK3 promote cell survival through phosphorylation and activation of SIRT1. J. Biol. Chem. 2010, 285:13223-13232.
25. +-dependent protein deacetylase activity of SIRT1 is regulated by its oligomeric status. Sci. Rep. 2012, 2:640.
26. Dixit D., et al. Inhibition of casein kinase-2 induces p53-dependent cell cycle arrest and sensitizes glioblastoma cells to tumor necrosis factor (TNFalpha)-induced apoptosis through SIRT1 inhibition. Cell Death Dis. 2012, 3:e271.
27. Kang H., et al. CK2 is the regulator of SIRT1 substrate-binding affinity, deacetylase activity and cellular response to DNA-damage. PLoS ONE 2009, 4:e6611.
28. Zschoernig B., Mahlknecht U. Carboxy-terminal phosphorylation of SIRT1 by protein kinase CK2. Biochem. Biophys. Res. Commun. 2009, 381:372-377.
29. Liu X., et al. Methyltransferase Set7/9 regulates p53 activity by interacting with Sirtuin 1 (SIRT1). Proc. Natl. Acad. Sci. U.S.A. 2011, 108:1925-1930.
30. +. Mol. Cell 2011, 44:851-863.
31. Yang Y., et al. SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress. Nat. Cell Biol. 2007, 9:1253-1262.
32. Kornberg M.D., et al. GAPDH mediates nitrosylation of nuclear proteins. Nat. Cell Biol. 2010, 12:1094-1100.
33. Nakamura T., Lipton S.A. Emerging role of protein-protein transnitrosylation in cell signaling pathways. Antioxid. Redox Signal. 2012, 18:239-249.
34. Kim E.J., et al. Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity. Mol. Cell 2007, 28:277-290.
35. Kim J.E., et al. DBC1 is a negative regulator of SIRT1. Nature 2008, 451:583-586.
36. Kang H., et al. Peptide switch is essential for Sirt1 deacetylase activity. Mol. Cell 2011, 44:203-213.
37. Yuan J., et al. Regulation of SIRT1 activity by genotoxic stress. Genes Dev. 2012, 26:791-796.
38. Escande C., et al. Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice. J. Clin. Invest. 2010, 120:545-558.
39. Pagans S., et al. SIRT1 regulates HIV transcription via Tat deacetylation. PLoS Biol. 2005, 3:e41.
40. Kwon H.S., et al. Human immunodeficiency virus type 1 Tat protein inhibits the SIRT1 deacetylase and induces T cell hyperactivation. Cell Host Microbe 2008, 3:158-167.
41. Alcain F.J., Villalba J.M. Sirtuin inhibitors. Expert Opin. Ther. Pat. 2009, 19:283-294.
42. Alcain F.J., Villalba J.M. Sirtuin activators. Expert Opin. Ther. Pat. 2009, 19:403-414.
43. Herranz D., Serrano M. SIRT1: recent lessons from mouse models. Nat. Rev. Cancer 2010, 10:819-823.
44. Hu Y., et al. The controversial links among calorie restriction, SIRT1, and resveratrol. Free Radic. Biol. Med. 2011, 51:250-256.
45. Schmidt C. GSK/Sirtris compounds dogged by assay artifacts. Nat. Biotechnol. 2010, 28:185-186.
46. Nakata R., et al. Recent advances in the study on resveratrol. Biol. Pharm. Bull. 2012, 35:273-279.
47. Grozinger C.M., et al. Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening. J. Biol. Chem. 2001, 276:38837-38843.
48. Peck B., et al. SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2. Mol. Cancer Ther. 2010, 9:844-855.
49. Mai A., et al. Design, synthesis, and biological evaluation of sirtinol analogues as class III histone/protein deacetylase (Sirtuin) inhibitors. J. Med. Chem. 2005, 48:7789-7795.
50. Bedalov A., et al. Identification of a small molecule inhibitor of Sir2p. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:15113-15118.
51. +-dependent deacetylases using phenotypic screens in yeast. J. Biol. Chem. 2003, 278:52773-52782.
52. Posakony J., et al. Inhibitors of Sir2: evaluation of splitomicin analogues. J. Med. Chem. 2004, 47:2635-2644.
53. +-dependent histone deacetylases (sirtuins). Bioorg. Med. Chem. 2011, 19:3669-3677.
54. Lain S., et al. Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator. Cancer Cell 2008, 13:454-463.
55. +-dependent histone deacetylases (sirtuins). ChemMedChem 2007, 2:1419-1431.
56. Bernofsky C. Physiology aspects of pyridine nucleotide regulation in mammals. Mol. Cell. Biochem. 1980, 33:135-143.
57. Catz P., et al. Simultaneous determination of myristyl nicotinate, nicotinic acid, and nicotinamide in rabbit plasma by liquid chromatography-tandem mass spectrometry using methyl ethyl ketone as a deproteinization solvent. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2005, 829:123-135.
58. Jacobson E.L., et al. Evaluating the role of niacin in human carcinogenesis. Biochimie 1995, 77:394-398.
59. Noriega L.G., et al. CREB and ChREBP oppositely regulate SIRT1 expression in response to energy availability. EMBO Rep. 2011, 12:1069-1076.
60. Heilbronn L.K., et al. Glucose tolerance and skeletal muscle gene expression in response to alternate day fasting. Obes. Res. 2005, 13:574-581.
61. Fusco S., et al. A role for neuronal cAMP responsive-element binding (CREB)-1 in brain responses to calorie restriction. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:621-626.
62. Nemoto S., et al. Nutrient availability regulates SIRT1 through a forkhead-dependent pathway. Science 2004, 306:2105-2108.
63. Xiong S., et al. FoxO1 mediates an autofeedback loop regulating SIRT1 expression. J. Biol. Chem. 2011, 286:5289-5299.
64. Brunet A., et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004, 303:2011-2015.
65. Motta M.C., et al. Mammalian SIRT1 represses forkhead transcription factors. Cell 2004, 116:551-563.
66. Purushotham A., et al. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab. 2009, 9:327-338.
67. Okazaki M., et al. PPARbeta/delta regulates the human SIRT1 gene transcription via Sp1. Endocr. J. 2010, 57:403-413.
68. Han L., et al. SIRT1 is regulated by a PPAR{gamma}-SIRT1 negative feedback loop associated with senescence. Nucleic Acids Res. 2010, 38:7458-7471.
69. Chen W.Y., et al. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Cell 2005, 123:437-448.
70. Zhang Q., et al. Metabolic regulation of SIRT1 transcription via a HIC1:CtBP corepressor complex. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:829-833.
71. Dehennaut V., et al. Molecular dissection of the interaction between HIC1 and SIRT1. Biochem. Biophys. Res. Commun. 2012, 421:384-388.
72. Abdelmohsen K., et al. Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol. Cell 2007, 25:543-557.
73. Yamakuchi M. MicroRNA regulation of SIRT1. Front. Physiol. 2012, 3:68.
74. Yamakuchi M., Lowenstein C.J. MiR-34, SIRT1 and p53: the feedback loop. Cell Cycle 2009, 8:712-715.
75. Ito T., et al. MicroRNA-34a regulation of endothelial senescence. Biochem. Biophys. Res. Commun. 2010, 398:735-740.
76. Zhao T., et al. MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. Am. J. Physiol. Endocrinol. Metab. 2010, 299:E110-E116.
77. Lee J., et al. A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition. J. Biol. Chem. 2010, 285:12604-12611.
78. Zhu H., et al. MicroRNA-195 promotes palmitate-induced apoptosis in cardiomyocytes by down-regulating Sirt1. Cardiovasc. Res. 2011, 92:75-84.
79. Rane S., et al. Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ. Res. 2009, 104:879-886.
80. Moynihan K.A., et al. Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice. Cell Metab. 2005, 2:105-117.
81. Ramachandran D., et al. Sirt1 and mir-9 expression is regulated during glucose-stimulated insulin secretion in pancreatic beta-islets. FEBS J. 2011, 278:1167-1174.
82. Strum J.C., et al. MicroRNA 132 regulates nutritional stress-induced chemokine production through repression of SirT1. Mol. Endocrinol. 2009, 23:1876-1884.
83. Gao Z., et al. Sirtuin 1 (SIRT1) protein degradation in response to persistent c-Jun N-terminal kinase 1 (JNK1) activation contributes to hepatic steatosis in obesity. J. Biol. Chem. 2011, 286:22227-22234.